Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Value in Health Regional Issues

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen? Patrick Marcellin, E. Jenny Heathcote,

R. Cavallo Clinical Microbiology and Infection

Volume 68, Issue 5, Pages (May 2018)

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 153, Issue 4, Pages (October 2017)

Hepatitis B and C virus-related carcinogenesis

Value in Health Regional Issues

Virological tools to diagnose and monitor hepatitis C virus infection

Living donor liver transplantation: is the hype over?

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

Jordan J. Feld, Graham R. Foster Journal of Hepatology

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 73, Pages S53-S68 (April 2008)

Yasuhiko Sugawara, Masatoshi Makuuchi

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Trends in the management and burden of alcoholic liver disease

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Acute hepatitis C: Current status and remaining challenges

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Volume 57, Issue 4, Pages (October 2012)

Autophagy in the liver Journal of Hepatology

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

EASL Clinical Practice Guidelines: Wilson’s disease

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Economics of chronic hepatitis B and hepatitis C

Hepatitis B and C virus-related carcinogenesis

HCV epidemiology in high-risk groups and the risk of reinfection

Volume 50, Issue 4, Pages (April 2009)

Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6

Volume 70, Issue 1, Pages (January 2019)

Immigration and viral hepatitis

HCV targeting of patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Volume 51, Issue 2, Pages (August 2009)

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Virology: a scientific discipline facing new challenges

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Genetics of hepatocellular carcinoma: The next generation

Outcomes in liver transplantation: Does sex matter?

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc, Linda Henry Journal of Hepatology Volume 65, Issue 1, Pages S109-S119 (October 2016) DOI: 10.1016/j.jhep.2016.07.005 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 How to capture the comprehensive benefits approach for measuring the burden of HCV to patients and to society. HCV, hepatitis C virus; EHM, extra-hepatic manifestations; HQRL, health-related quality of life; WP, window phase; ICER, incremental cost-effectiveness ratio; PRO, patient related outcomes. Journal of Hepatology 2016 65, S109-S119DOI: (10.1016/j.jhep.2016.07.005) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 HCV and progression of liver disease. HCV, hepatitis C virus; SVR, sustained virological response; HCC, hepatocellular carcinoma; USA, United States of America. Journal of Hepatology 2016 65, S109-S119DOI: (10.1016/j.jhep.2016.07.005) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions